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Mass casualty incidents (MCIs) and disaster medical situations are ideal settings in which there is need for a novel approach
to infusing ﬂuids and medications into a patient’s intravascular space. An attractive new approach would avoid the potentially
time-consuming needlestick and venous cannulation requiring a trained practitioner. In multiple-patient situations, trained
practitioners are not always available in suﬃcient numbers to enable timely placement of intravenous catheters. The novel
approach for intravascular space infusion, described in this paper involves the preadministration of the enzyme, human
recombinant hyaluronidase (HRH), into the subcutaneous (SC) space, via an indwelling catheter. The enzyme “loosens” the SC
space eﬀectively enhancing the absorption of ﬂuids and medication.
1.Introduction
Hyaluronidase-facilitated subcutaneous infusion (HRH-
SCI), also denoted by “enzymatically assisted subcutaneous
infusion” (EASI), appears based upon available evidence to
be an easy, safe, and eﬀective means of infusing ﬂuids and
somemedicationsintotheintravascularspace.Therelevance
of EASI to the prehospital setting appears to be highest in
the disaster/MCI arena, where there may be limited numbers
of practitioners treating numerous persons. In short, EASI
may be a partial solution to the problem of mismatch
between numbers of patients requiring intravascular access
and capabilities of available providers to provide that access.
Building on reports of EASI use in other settings,
namely, in hospice care and in pediatric patients, prehospital
investigators have assessed EASI as placed by ﬁrst EMT-
paramedics (EMT-Ps) [1] and then in a follow-up study with
EASI placed by EMT-basic (EMT-B) level providers [2]. In
its ﬁrst two studies in simulated prehospital situations, EASI
access was placed with 100% eﬀectiveness and no signiﬁcant
complications.
This paper is not intended to be a comprehensive
treatment of the complex subject of prehospital vascular
access and ﬂuids/medication administration. Rather, the
intent is to brieﬂy outline the possible role for a novel
approach to the long-standing challenge of access. The paper
will open by making a case for the need to investigate new
avenues for intravascular access. Next, we will outline the
existing work with EASI access and infusion as performed
by prehospital personnel. The paper concludes with consid-
eration of potential future directions for EASI research and
application.
2. The Rationale for Considering a Novel Route
of Access to the IntravascularSpace
2.1. Importance of Intravascular Access. The most vital
component of the case for importance of access to the
intravascular space is the consistent message in the literature,
that out-of-hospital hydration is often critical. Experts aver
that administration of ﬂuids in the out-of-hospital setting
remains an important intervention in disaster and MCI
circumstances [3–5]. Clinical practice as well as standard
emergency medicine and trauma resuscitation teaching
emphasizes the importance of early ﬂuid resuscitation for a
variety of injuries and illnesses [5]. The literature addressing
MCI situations (e.g., crush injuries) makes a strong case2 Emergency Medicine International
for the importance of ﬂuid replacement [3]. Therefore,
for ﬂuid resuscitation alone, there is a strong case to be
made that access to the intravascular compartment is an
important priority for prehospital providers (particularly in
disaster/MCI situations). Fluid administration as considered
herein includes glucose-containing ﬂuids such as D5NS
(normal saline with dextrose 5%).
2.2. Challenges in Obtaining Vascular Access in the Out-of-
HospitalSetting. Despitethewidespreadacknowledgmentof
the importance of prehospital intravascular access, obtaining
that access through the traditional intravenous (IV) line is
notalwayssimple.Asisthecasewithmanyotherprocedures,
that which is usually straightforward in the hospital and
emergency department (ED) setting can be diﬃcult in the
ﬁeld.
The out-of-hospital setting can pose special challenges to
the provider attempting to gain access to the intravascular
compartment. These challenges can be categorized as being
related to establishing an individual patient’s IV, or those
being related to establishing access in a large number of
patients.
In an individual patient encounter, placement of an IV
catheter may be hampered by a number of situations. The
anatomy may be diﬃcult, as is the case with venous collapse
in hypotension. Positioning issues (e.g., entrapment) may
render it diﬃcult to reach the vein. IV access placement
problems may be compounded by environmental condi-
tions ranging from inadequate lighting to jarring vehicular
motion.
Indailypracticeinthesingle-patientsetting,experienced
ﬁeld practitioners usually rely on training and experience
as they overcome IV access diﬃculties and achieve access.
Nonetheless, there are certainly cases in which the problems
are not surmounted and prehospital IV access either fails or
requires multiple attempts. In these situations, there may be
roomintheprehospitalarmamentarium,foranewapproach
to the intravascular compartment.
Thesituationwithrespecttomultiple-patientencounters
(such as MCI situations) may be characterized by just the
same problems as those described for individual attainment
of prehospital IV access, but on a larger scale. A few-minute
delay in attaining IV access in an individual patient is not
often life threatening. That same delay can cause major
morbidity in a situation in which a small group of providers
is faced with starting dozens of IVs in a diﬃcult situation. In
a disaster or MCI situation, there may actually be insuﬃcient
healthcare provider resources to place IV access in a timely
fashion, even if the IV placement goes smoothly in each
individual patient. A lesser concern, but one warranting
mention, is the fact that repeated venipuncture attempts
may cause pain that is rated as “signiﬁcant” by patients and
parents [6–11].
The “bottom line” of the challenges that can face
prehospital providers attempting to establish IV access in
the ﬁeld is that in some cases there is room for a new
approach. Whether the problem is repeated IV “sticks” in a
given patient, or the need to establish dozens of intravascular
access lines in a short time period, there is potential utility
in a rapid, easily taught, and simple system for establishing
reliable access to the intravascular compartment.
2.3. Limitations in Alternatives to IV Access. The need for
assessing alternative mechanisms for intravascular compart-
ment access has already been recognized. Noting the signiﬁ-
cance of the problems that can occasionally be encountered
in the ﬁeld execution of IV access, trauma researchers
have investigated alternative methods of hydration, such
as proctoclysis, infusion of ﬂuids into the rectum [12]. If
the need for alternative methods of ﬂuid administration is
suﬃcient to prompt serious consideration of proctoclysis—
the drawbacks of which are not limited to impracticality, the
search for alternative routes to the intravascular compart-
ment should include SC infusion (which is much easier to
place and better tolerated).
The main alternative at this time, to IV access, is the
intraosseous (IO) line. Just as IV cannulation is the usual
answer to the question of how to obtain intravascular
access, IO access has historically been the (only) alternative
approach. To be clear, there is a deﬁnite role for IO lines
in out-of-hospital care. However, the myriad situations
that may be encountered in the ﬁeld, combined with the
disadvantages of IO lines, make a case for assessing viability
of a non-IO approach. IO lines have an acknowledged role in
prehospital medicine, but their risks include pain, extravasa-
tion, infection, and fracture. IO placement is not necessarily
quick, and the capability to perform the procedure requires
initial and ongoing skills maintenance [13, 14]. One study
found that while 18 of 19 IO lines appeared to be correctly
placed on initial attempt, there were 5 cases with serious
complications (e.g., dislodgment, extravasation, failure of
infusate to ﬂow), leading to an overall IO success rate of 68%
[14]. In about a third of the cases, IO placement required
over a minute to establish [14].
The just-cited literature does not mean that there is not
a role for IO lines in out-of-hospital care. IO is occasionally
useful (and even life saving). However, the limitations of IO
and other currently used alternatives to IV access do leave
room for assessment of a possible role for a new mechanism
to get to the intravascular space.
3. ExistingEvidence andMethod for Use of
Subcutaneous Infusion
3.1. Physiology of HRH-Assisted SC Infusion. An o w -
outdated term for SC ﬂuid infusion, “hypodermoclysis,”
was in use for decades [15]. For all practical purposes,
the practice ceased in the USA with the arrival of modern
IV catheter equipment, but SC infusion is still in use in
some settings [15, 16]. In addition to the fact that “new”
(nonmetal) IV catheters were simple to use and quite
safe, hypodermoclysis abandonment was due in part to the
physiology of the SC interstitial matrix which serves as the
main barrier to diﬀusion of SC-administered ﬂuid.Emergency Medicine International 3
The extraadipocyte portion of the SC compartment is
a gel-like matrix of collagenous ﬁbrils and glycosamino-
glycans. Subcutaneously administered drugs and infusates
must traverse this interstitial matrix to enter the vascular
or lymphatic system. The interstitium resistance to drug
permeation can be envisioned as functioning like a three-
dimensional ﬁlter through which drugs/infusates must pass.
There are large molecules such as elastin and collagen
inhabiting a matrix of hydrated gel-like glycosaminoglycans
andproteoglycans.Amongthemostimportantglycosamino-
glycans (for purposes of this review) is hyaluronan, which
contributes to the resistance of ﬂuid ﬂow through the inter-
stitium. Though hyaluronan is found in lower concentration
than collagen in the skin, it plays a disproportionately large
role in resisting ﬂuid movement [17].
Hyaluronidase modiﬁes connective tissue permeability
via hydrolyzing hyaluronic acid, eﬀecting a cleavage of
the glucosaminidic bond between N-acetylglucosamine and
glucuronic acid moieties. The cleavage results in a decrease
in viscosity of the cellular cement and promotes diﬀusion
of injected ﬂuids, facilitating their absorption. The decrease
in viscosity is reversed within 24 hours, due to the rapid
inactivation of the hyaluronidase enzyme and also due to the
rapid turnover rate of skin hyaluronan [18–20].
Hyaluronidase-spreading agents, historically derived
from animal extracts, have been used clinically to facilitate
dispersion and absorption of other drugs for over 50 years
[18]. This long history of successful use contributed to a
relatively rapid FDA approval for HRH (in 2005), which
states the drug is “indicated as an adjuvant to increase
the absorption and dispersion of other injected drugs,
for hypodermoclysis, and as an adjunct in subcutaneous
urography for improving resorption of radiopaque agents”
[21].
3.2.EASIAccesstotheIntravascularCompartment. TheHRH
used in the most recent literature on SC infusion has as its
main advantage over previous hyaluronidase products the
absence of immunogenicity. As a human recombinant agent,
HRH poses far less allergy/anaphylaxis risk (essentially,
none) as compared to animal-derived hyaluronidase. The
HRH otherwise works as described above, in facilitating
“spread” of ﬂuids and medications administered into the SC
space.
The concept of using HRH in actual patients has
been demonstrated feasible and eﬀective. The initial clinical
experience concentrated on the hospital and hospice settings
[18, 22]. Hospice patients needed indwelling catheters for
delivery of ﬂuids and analgesia, and pediatric patients in
the hospital beneﬁted from rapidly placed lines that served
as a mechanism for hydration [23]. These studies revealed
that the HRH-facilitated hydration was very easily placed,
lasted for many hours (or days) without complication, and
alleviated the need for IVs.
The studies with the most likely relevance to the pre-
hospital and MCI situation are probably the EASI Access I
and EASI Access II trials (conducted in part by some of this
review’sauthors)[1,2].Thesestudiesareimportant,because
oftwomajor“new”angles:(1)institutionofHRH-facilitated
infusion lines by prehospital providers and (2) use of stable-
isotope labeling techniques to deﬁnitively demonstrate rapid
andsigniﬁcantuptakeintotheintravascularcompartmentof
SC-infused (glucose-containing) ﬂuid.
In EASI Access I, 4 EMT-Ps instituted EASI access in 20
healthy volunteers. The EASI access lines were successfully
placed in under 15 seconds, in all study subjects. Normal
salinewith5%dextrose(someofwhichwas 13C-labeled)was
infused at rates that were held at no more than 150mL/hour.
Gaschromatography/massspectrophotometry(GC/MS)was
used to demonstrate uptake of the isotopic glucose in the
infusate, as early as 15 minutes into the infusion (this was the
ﬁrst time of analysis). Since the EASI access lines were placed
more quickly than IV lines, and since the infusates were
administered with zero signiﬁcant adverse eﬀects, the study
concluded that EMT-P administration of ﬂuids and glucose
via EASI was likely a viable option for some prehospital
circumstances.
EASI Access II followed up the result of EASI Access I,
by assessing the placement of HRH-facilitated SC infusion
lines by EMT-Bs. This was undertaken after the EASI Access
I investigators observed that the placement of the EASI
access lines appeared to require very little medical expertise
and minimal training. EASI Access II main ﬁndings were
(1) conﬁrmation of rapid and consistent uptake of SC-
infused labeled glucose (as detected with GC/MS at the
ﬁrst assessment time, 5 minutes into infusion) and (2)
demonstration of 100% success rates in rapid and eﬀective
establishment of EASI access in 18 subjects by 18 EMT-B
practitioners (the same 18 individuals served as both study
subjects and the EASI line placement operators). In EASI
Access II, the infusate of 5% dextrose in water (D5W) was
administered at a median rate of 400mL/hour.
3.3. Mechanism for Use of EASI Access. One reason that EASI
access appears to be attractive for use in the prehospital
setting is that the technique requires minimal training and
little in the way of additional supplies. The EASI Access I and
II studies each entailed no more than 5–10-minute training
(time varied depending on time required by each subject
to reach comfort level). Furthermore, the HRH used comes
in unit-dose vials that are easily reconstituted before being
administered through an initially placed SC line in a dose of
150 units (1mL).
First comes placement of the SC line. A fold of skin—
preferably on the upper back as this area is accessible
and allows for painless ﬂuid administration—is pinched
(Figure 1). Into the fold is placed a standard IV catheter;
22- or 24-gauge catheter works well but sizes can be varied
(Figure 2). After the catheter is taped into place, HRH is
administered into the catheter in a painless step that begins
bythinning oftheSCtissues.Finally,standardIVtubing isto
be connected and secured. A photo of an EASI line in place
is depicted in Figure 3.
It is noteworthy that the upper back location is not
required. Any location that is accessible in a given situation
may serve as the access point for an EASI line. Locations in4 Emergency Medicine International
Figure 1
Figure 2
which the subcutaneous space may be “tight” (e.g., dorsum
of the hand) may theoretically be associated with infusion
discomfort that is not seen with locations in the upper arm
or the back.
Regardless of where EASI is placed, it is sensible to
begin with a low infusion rate, increasing the ﬂuid infusion
pace only after conﬁrmation of painless infusion at lower
rates. The authors have found that infusion rates in the
400mL/hr range are easily attainable (and painless) [1,
2]. Other investigators have used small-gauge catheters
(24g) and infused isotonic solution (lactated Ringer’s) with
no discomfort, at maximal gravity-assisted rates exceeding
500mL/hr [24].
The best ﬂuid to be chosen is probably the one that
contains glucose. Glucose is an important component of
ﬂuids in prehospital (especially MCI) situations, and EASI
Access I and II clearly demonstrated rapid and signiﬁcant
uptake of EASI-infused glucose into the intravascular space
[1, 2]. Palliative care and hospice data include reports of
painless administration of a breadth of ﬂuids including
normal saline (NS) and variants with and without dextrose
(e.g., D5NS, D5 0.5 NS); 5% dextrose in water (D5W) has
also been infused without problems [25].
4.FutureResearch andPractice Directions
The preceding information paints a tantalizing, if incom-
plete, picture of a novel method of ﬂuid administration.
Since IV access is markedly more of a problem in the
Figure 3
prehospital setting than in the hospital, and since the
diﬃculties are magniﬁed in MCI situations, the relevance of
EASI access to out-of-hospital care may prove to be high.
One question that arises is whether prehospital providers
can adjudicate which cases may be appropriate for SC
infusion. Just as prehospital providers currently exercise
(protocol-guided) judgment as to who requires IV (or IO)
access, those providers can appropriately triage patients to
SC infusion. It appears possible that, in some cases where IV
access fails, SC may be a more viable option for rapid ﬂuid
and medication administration than IO (e.g., when patient
requirements are for minimal ﬂuids and rapid analgesia).
The guidance for prehospital personnel and respondents to
disasters or MCIs will need to include consideration of both
individual patients and aggregate situations.
The existing literature demonstrates administration of a
variety of ﬂuids, as well as glucose and opioid analgesia (in
the palliative care setting) [15, 24, 25]. Future focus should
include assessment of which agents may be administered via
EASI, with safety and eﬃcacy. Fluids and analgesia are a
reasonable starting point (especially since the latter may be
given both SC and IV already), but there remain possibilities
for other agents’ administration (e.g., midazolam) after
appropriate research.
In our area, meteorological disasters (especially torna-
does) occur with unfortunate frequency. Situations in which
dozens (or scores) of patients with mild-moderate injury,
who need ﬂuid resuscitation, are easily imagined. Our next
EASI Access III study is planned to include administration
of EASI access in actual prehospital patients for whom
IV access fails and in whom prehospital providers do not
judge IO placement as appropriate. This study will be a
good assessment of the use of EASI access in routine pre-
hospital ﬂuid administration. HRH is also being planned
for utilization with our local disaster response teams, in
anticipation of caring for large numbers of patients or
individual disaster patients with need (e.g., entrapment
and no IV access). Another use of EASI access worthy of
investigation is its eﬀect on subsequent IV access attempts
in patients who need improved intravascular volume or with
increased interstitial edema.
It appears that the existing evidence, while not estab-
lishing a concrete role for EASI access in the prehospital
setting, does support the continued investigation of thisEmergency Medicine International 5
FDA-approved approach for ﬂuid resuscitation in the ﬁeld.
Time will tell whether SC infusion proves a useful part of the
prehospital and disaster armamentarium.
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